Eleven P15
Denver, US · Founded 2016 · Delaware corporation
Eleven P15 is a company focused on the genetics of pulmonary fibrosis, with work spanning biomarker development, genomics, and animal models of human disease.
Founders & leadership
Eleven P15 was founded in 2016 by David Schwartz.
DS
David SchwartzCSO
BS
Bruce SchroffelNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2019
▶$1.6MraisedNov 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1.6MraisedNov 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce SchroffelExecutive Officer
- David SchwartzExecutive Officer, Director, Promoter
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Eleven P15 do?
- Eleven P15 is a company focused on the genetics of pulmonary fibrosis, with work spanning biomarker development, genomics, and animal models of human disease.
- Who founded Eleven P15?
- Eleven P15 was founded by David Schwartz in 2016.
- How much funding has Eleven P15 raised?
- Eleven P15 has disclosed $1.6M raised across 1 round.
- Where is Eleven P15 headquartered?
- Eleven P15 is headquartered in Denver, US.